Presentation is loading. Please wait.

Presentation is loading. Please wait.

L Alvarez 2018 Adjuncts to Steroid Treatment

Similar presentations


Presentation on theme: "L Alvarez 2018 Adjuncts to Steroid Treatment"— Presentation transcript:

1 L Alvarez 2018 Adjuncts to Steroid Treatment
Choroidal ischemia/ perfusion delay behind transient or other visual loss without infarcted disc in GCA Arteritic disc : acute pale swelling with (usually if temporal disc involved) very poor vision (+++ suggestive) Suspected Giant Cell Arteritis (GCA) presenting to the BMEC Accident and Emergency Suspect Acute ocular ARTERIAL ischemic signs ( ischemic optic neuropathy, retinal ischemia, amaurosis fugax/ transient visual loss) new onset non explained visual disturbance or diplopia in patient > 50. (* note GCA is very rare in non-caucasians, but not impossible). Typical Systemic Symptoms? (can be absent [20%]) Scalp pain or tenderness Jaw claudication Limb claudication Hip/shoulder girdle pain and stiffness Lethargy, malaise, fever, weight loss, Supportive Examination? Thickened, tender or non-pulsatile TAs Cranial nerve / compatible visual signs/ symptom Peripheral pulses – inequality/absence/bruits High Acute Phase Response? Urgent FBC, U&E, LFT, ESR, CRP, Glu, INR, (HbA1c) Pre-test probability : GCA still suspected? High suspicion : Raised inflammatory markers + systemic signs, compatible or patognomonic ocular presentation (arteritic AION) High suspicion Low suspicion Intermediate suspicion Raised inflammatory markers, absent or few systemic symptoms, compatible / possible ocular presentation Consider alternative cause eg if amaurosis fugax = TIA? Embolic source  urgent referral stroke pathway No visual symptoms (eg GP referral with very suggestive systemic symptoms), raised inflammatory markers Impending (acute visual symptoms) or established visual loss Consider risk/benefit of high dose steroids and probability of pre-test diagnosis before commencing steroids Consider urgent admission (if visual loss/ visual symptoms) for IV steroids Organise TAB Medical assessment/ Fill out referral leaflet Urgent referral to neuro-ophthalmology Commence FIRST dose of steroids (oral MG OD) Organise TAB/ Doppler TA Medical assessment/ Fill out referral leaflet Urgent referral to rheumatology Admit and commence FIRST dose of steroids STAT * and organise temporal artery biopsy (TAB) Medical assessment/ Fill out referral leaflet Start AAS if no contraindication Referral to rheumatology/ neuro-ophthalmology STEROIDS and High suspicion GCA * Some evidence supports IV versus oral steroids in GCA with acute visual loss, in GCA but if delays are expected/ unavoidable for intravenous administration, start oral stat in the Accident and Emergency department. Assess risk/ benefit of oral versus IV (oral may be preferable in CKD/ electrolite imbalance/ cardiac failure/ diabetes) In high suspicion GCA, first dose of steroids must not be delayed. Chest X ray should be organised acutely on starting steroids but never delaying first dose. Dose of intravenous steroids : 15 mg/kg BW Methylprednisolone (up to 1g per day) for 3 days when acute visual loss / impending visual loss. Alternative: 60 mg oral prednisolone Steroids for treatment of GCA are maintained (always under rheumatology guidance) 40mg or 60mg for 4 weeks - or longer until symptoms resolved- then reduce dose by 10mg every 2 weeks until 20mg, then reduce dose by 2.5mg every 2 weeks until 10mg, then reduce dose by 0.5-1mg every 2 months Adjuncts to Steroid Treatment Prednisolone oral tablets – non-enteric coated – dose as per pathway Aspirin 75mg OD to prevent (further) neuro-ophthalmic complications Proton pump inhibitor (PPI) or H2 antagonist for gastroprotection Calcium and vitamin D supplement and Bisphosphonate (if no contraindication – consider renal function, previous peptic ulcer disease etc.) Medical assessment Always document full medical history : cardiac or renal failure, diabetes, other systemic comorbidities? If present : medical review by medical team (rheumatology) as inpatient, consider adjusting dose of steroids

2 Sandwell and West Birmingham NHS Trust
Suspected Giant Cell Arteritis (GCA) Care Pathway - Referral form – draft 1 Surname: Forename: Location of Patient: Eye casualty Date of Birth: Ward GP practice Hospital (RXK) or NHS no: Patient Tel.number: Symptoms: (circle yes / no) Investigations: Scalp pain or tenderness yes / no ESR (mm/h) Jaw claudication yes / no Visual loss or blurring, diplopia yes / no CRP (mg/L) Hip/shoulder girdle pain or stiffness yes / no Lethargy, malaise, anorexia, weight loss yes / no GFR ml/min Fever yes / no Limb claudication yes / no Plts x109/L Signs: (circle as appropriate) INR……………………………………… Temporal artery / branches tender No – R – L – Both Temporal artery / branches thickened No – R – L – Both Temporal pulses absent No – R – L – Both Description of visual symptoms and signs Amaurosis fugax / Ischemic optic neuropathy/ Other (specify ) R – L – Both …………………………………………………………………………………………………………………………………………………………… Comorbidities: (circle) Diabetes Osteoporosis CKD Ischaemic heart disease other (please state) Drug Treatment (circle) Aspirin Warfarin/Rivaroxaban/Clexane etc. Bisphosphonate PPI or H2 antagonist Calcium/vitamin D other (please state) ACTION BY REFERRER: Dose of Prednisolone commenced? Date: ...../...../..... TA Ultrasound (US skull on iCM) scheduled? yes/no Date: ...../...../..... Print Name: Contact tel./bleep Signature: Date: ...../...../..... FAX REFERRAL TO (City) OR (Sandwell) PLEASE CALL (City) OR (Sandwell) TO CONFIRM RECEIPT Contact Rheumatology SpR at City / Sandwell Hospital or Consultant on-call via Switch if queries


Download ppt "L Alvarez 2018 Adjuncts to Steroid Treatment"

Similar presentations


Ads by Google